Literature DB >> 11292668

Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension.

Y Mukai1, H Shimokawa, T Matoba, T Kandabashi, S Satoh, J Hiroki, K Kaibuchi, A Takeshita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11292668     DOI： 10.1096/fj.00-0735fje

Source DB:  PubMed          Journal:  FASEB J        ISSN： 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  63 in total

Review 1.  The role of Rho protein signaling in hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Nat Rev Cardiol       Date:  2010-08-31       Impact factor: 32.419

2.  Heterogeneous Impact of ROCK2 on Carotid and Cerebrovascular Function.

Authors:  T Michael De Silva; Dale A Kinzenbaw; Mary L Modrick; Lindsey D Reinhardt; Frank M Faraci
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

3.  Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt.

Authors:  Yasushi Mukai; Yoshiyuki Rikitake; Ichiro Shiojima; Sebastian Wolfrum; Minoru Satoh; Kyosuke Takeshita; Yukio Hiroi; Salvatore Salomone; Hyung-Hwan Kim; Laura E Benjamin; Kenneth Walsh; James K Liao
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

Review 4.  Role of rho kinase in the functional and dysfunctional tonic smooth muscles.

Authors:  Márcio A F de Godoy; Satish Rattan
Journal:  Trends Pharmacol Sci       Date:  2011-04-15       Impact factor: 14.819

5.  Changes in cardiac Na+/K+-ATPase expression and activity in female rats fed a high-fat diet.

Authors:  Aleksandra Jovanovic; Milan Obradovic; Emina Sudar Milovanovic; Alan J Stewart; Samantha J Pitt; Dragan Alavantic; Ema Aleksic; Esma R Isenovic
Journal:  Mol Cell Biochem       Date:  2017-05-31       Impact factor: 3.396

6.  Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor.

Authors:  Paulo W Pires; William F Jackson; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

7.  The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells.

Authors:  Kumiko Goto; Yoshihiko Chiba; Kimihiko Matsusue; Yoshiyuki Hattori; Yoshie Maitani; Hiroyasu Sakai; Shioko Kimura; Miwa Misawa
Journal:  Pharmacol Res       Date:  2009-12-17       Impact factor: 7.658

8.  Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle.

Authors:  Maria Regina Freitas; Masumi Eto; Jason A Kirkbride; Christa Schott; Jean Sassard; Jean-Claude Stoclet
Journal:  Fundam Clin Pharmacol       Date:  2009-03-09       Impact factor: 2.748

Review 9.  The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.

Authors:  Karl Swärd; Mitsuo Mita; David P Wilson; Jing Ti Deng; Marija Susnjar; Michael P Walsh
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

10.  Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction.

Authors:  Dedmer Schaafsma; Reinoud Gosens; I Sophie T Bos; Herman Meurs; Johan Zaagsma; S Adriaan Nelemans
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.